Page 5 - 《中国药房》2022年7期
P. 5

CHINA PHARMACY

                               Volume 33,Number 7,April 15,2022

                                                 Semimonthly
                                             Table of Contents



        Drug selection guideline for medical institutions …… LI Zhengxiang,ZHANG Yu,ZHANG Lingli,DUAN Rong(769)
        Policy analysis of high-quality development of traditional Chinese medicine based on PMC index model ………

          ………………… WANG Yujia,ZHANG Wan,WU Rui,HAN Liangfu,LI Yueming,FENG Yichong,HU Qizhi(777)
        Effects of drug circulation supervision on online drug retailing within different time spans ……… CHANG Wei(783)
        Status quo and problem analysis of market operation and management of DTP pharmacies in Guizhou province
          ……………………………………… FAN Xingying,CHANG Yue,ZHOU Hanni,LI Duan,HUANG Mingcan(789)
        Analysis of allocation of antipsychotics in regions with different economic levels in Shandong province …………
          ………………………………………………………………………………… MA Wenwen,YIN Jia,SUN Qiang(795)
        Full spectrum analysis of chemical constituents of Sargassum fusiforme and its in vitro anti-neuroinflammatory

          activity ……………………………………………………………………………………………… PENG Hong,
          HUANG Pinzhe,SONG Yonggui,XU Huanhua,ZHOU Mingyue,ZHU Genhua,YANG Ming,AI Zhifu,SU Dan(800)
        Study on the content determination method of five active components and fingerprints of Yixin badiran jibuya
          granules ……………………………………… LI Honghong,Payman·Hermity,WANG Xinchun,HE Chenghui(808)
        Preparation of folate-targeted anti-miR-221 anionic liposome and its in vitro anti-hepatocellular carcinoma effect
          ………………………………………………………… ZHANG Wendian,CUI Jie,XIA Yifan,DUAN Shaofeng(813)
        Study on the improvement of Compound danshen tablets on blood lipid levels and the mechanism of protecting
          renal functions in hyperlipidemia model rats ………………………………………………………………………

          ………………… ZHANG Minghao,GAO Yiying,DONG Wenxia,WANG Zhen,XUE Pengkun,MA Weiyang(818)
        Analysis of quality difference of different specifications and different origins of Citri Grandis Exocarpium ………
          ………………………………………………………………………………………………………… GAO Zelin,
          ZHANG Xiaoying,MAI Baoyu,LIN Xiating,FANG Jiaqi,ZHONG Jiarui,ZHAN Ruoting,XIAO Fengxia(825)
        Effects of different processing methods on the contents of the pharmacodynamic index components and antioxidant
          activity of Citrus aurantium …………………………………………………………………………………………
          ……………………… WANG Lu,WANG Lixia,WU Tingting,ZHAO Siqing,ZHENG Meiyu,LU Shengmin(830)

        Neuroprotective effect and the mechanism of Shenzao jiannao oral liquid on Alzheimer’s disease model mice …
          …………………… JIN Xian,CHEN Jicong,XIN Yuying,XIAO Honghe,LI Yan,DENG Yan,YANG Jingxian(836)
        Study on quality grade standard of premature Forsythia suspensa ……………………………………………………
          WEI Zhijiang,REN Xiaohong,ZHANG Ye,DAI Xi,GUO Ran,ZHAO Zihan,LIU Lulu,LIU Yong,LI Weidong(842)
        Preparation of cinnamaldehyde loaded liposomes bilayer-modified by bovine serum albumin/chitosan ……………
          ……………………………… WEI Zheng,YANG Sen,LUO Zhengkang,SHA Ou,LUO Zhidan,ZHANG Jian(848)
        Component analysis of ethyl acetate fraction in Qubai tablet and its pharmacodynamic study on de melanocyte
          model of mice ………………… DUAN Songleng,GU Hongyan,NIAN Honglei,XING Ruo,JIANG Dechun(853)
        Study on the salt-processing technology of Rosa laevigata and its HPLC fingerprints and chromaticity values

          before and after salt-processing ……………………………………………………………………………………
          …… ZHANG Hongtao,ZHANG Jing,MENG Lingxu,ZHU Zhenghua,MENG Xiangjun,ZHANG Xiaohuan(861)
        Application of adjusted limited dependent variable mixed model in the mapping of pharmacoeconomic health
          utility scale ………………………………………………………………………… WAN Chuchuan,XU Huaifu(867)
   1   2   3   4   5   6   7   8   9   10